top of page
바이오 디자이너스 최종.png

We will make
Your dreams come true!

BioDesigners is a company that grows together by discovering innovative bio and healthcare technologies.

​Send us your ideas!

COMMERCIALIZATION
PARTNERS

SERVICES
이뮤노 디자이너스 로고 원본.png

To develop a new immuno-related drug,

we co-founded IMMUNO DESIGNERS in December 2020 with Professor Bruce A. Beutler of the UT Southwestern Medical Center, a world-renowned scholar.

​

Dr. Beutler used a mouse to discover that TLR recognizes pathogens directly, and for this contribution, he won the The Nobel Prize in Physiology or Medicine in 2011. This led to a shift in the perception that innate immunity is controlled not by simple inflammatory reactions but by developed signal transmission systems, and the mechanism of immune system activation was revealed, effective treatments for immune diseases such as autoimmune diseases, allergies, and asthma were developed.

OUR TEAM

 

Lee, Dongho

​

-Professor, Hanyang University College of Medicine,

 Anesthesiology

-Yale University Medical School Hospital  visiting professor

-Vice President of GlaxoSmithKline Korea  Medical Director

-Vice President of Samyang Corporation Head of

 Pharmaceutical Business Division  Head of Research

 Center

-Professor of Anesthesia and Pain Medicine, Department of Clinical Pharmacology, Ulsan University College of Medicine

-Director, Clinical Research Center, Asan Medical Center, 

 Seoul

-Vice President of korea national enterprise for clinical trials(KoNECT) / Clinical Trial Center selection and guide

-Ceo of Korean Drug Development Fund(KDDF)

-Korea Pharmaceutical and Biotechnology Association AI

 Director of New Drug Development Support Center

 

Kim, Myung Hwa

​

- Master of Pharmacy and Doctor of Chemistry,

  University of Mainz,Germany
- Senior Researcher at Chugai Pharma, Fuji Gotemba

  Research Labs., Japan
- General Manager at the Central Research Institute of

  Citree Co., Ltd

- Director of Division of New Drud Development, R&D

  Centerb of Jeil Pharmaceutical Co., Ltd. Korea
- Director at R&D Center, Arimed Therapeutics. Korea

- CSO/Project Evaluation & Management Team Leader

  of Korea Drug Development Fund (KDDF)

- CSO/President at The Curacle Co., Ltd, Korea

 

Oh, Sungsoo

​

 -Solidus Global Bioagrifood Fund (17 billion won)

  Representative fund manager (completed  liquidation, 

  IRR 17%)

 -IBKC-Solidus Future Creation Bio-Secondary Refund

  Fund

  (30 billion won) Representative fund manager

 -KB-Solidus Global Healthcare Fund (150 billion won)

  Representative fund manager

 -2014 Solidus Growth Ladder Startup Fund

  (20 billion won) Core operating area

 -Pan-Ministry of Health and Welfare Development   

  Project Team  Investment Review Board

 -Korea Biotechnology Association  Advisory  Committee

 -Samsung Seoul Hospital, etc.  Evaluation Committee

 -Ministry of Welfare, Ministry of Industry, Ministry of

  Science and Technology, etc.  Government bio

  advisory&Evaluator

​

MEDIA COVERAGE

ARTICLES
bottom of page